STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
324
13F, latest reported quarter
Conversions, 180 days
80
Codes C/M, not in net · no price filed
What the filings say about DT
Insiders, 180 days
-$2.9M net sold
1 seller · 14% of sales under a 10b5-1 plan
Congress, 1 year
0 bought · 1 sold
Latest: sale, 2026-01-09
Planned sales (Form 144), 90 days
$2.9M
1 notice
Activist stakes (13D), 180 days
2 filings
Largest: 5.0% of the class
Dynatrace insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Dynatrace, Inc. insiders sold a net $2.9M of stock across 202 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
38 earlier Form 4 trades (code P or S) here by this insider (38 sales), the last on Sep 5, 2026.
The trade is 5.5% of the 904,846 shares held after it.
No other insider sold within 30 days.
324 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Chief Technology Officer Greifeneder Bernd sold about $2.9M of DT under a 10b5-1 plan on Sep 18, 2026, the largest insider sale at the company since 2025; 324 funds added in the latest 13F quarter.
Funds ranked by the share of their own portfolio in this stock (N-PORT).
PAPP SMALL & MID-CAP GROWTH FUND
$1.9M position · as of 2026-05-31
4.8%
TimesSquare Quality Mid Cap Growth ETF
$1.6M position · as of 2026-05-31
3.6%
CresAlta Small and Mid-Cap ETF
$2.6M position · as of 2026-07-31
2.7%
BARON DISCOVERY FUND
$48.8M position · as of 2026-06-30
2.7%
Baron SMID Cap ETF
$866.5K position · as of 2026-06-30
2.6%
First Trust Nasdaq Cybersecurity ETF
$283.3M position · as of 2026-06-30
2.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · John Van Siclen
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2020
$8.4M
$25.4M
n/a
n/a
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. This filer reported no return figures.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
The record shows a net $2.9M sold by insiders over 180 days, 324 funds added last quarter, $2.9M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.1B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM DT
FY Mar 2026
$2.0B
FY Mar 2025
$1.7B
FY Mar 2024
$1.4B
FY Mar 2023
$1.2B
FY Mar 2022
$929.4M
Jun 2026
$554.5M
Mar 2026
$531.7M
Dec 2025
$515.5M
Sep 2025
$493.8M
Jun 2025
$477.3M
Mar 2025
$445.2M
Dec 2024
$436.2M
Sep 2024
$418.1M
At each fiscal year end
Single quarter
Net margin, TTM
+7.2%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM DT
FY Mar 2026
+8.1%
FY Mar 2025
+28.5%
FY Mar 2024
+10.8%
FY Mar 2023
+9.3%
FY Mar 2022
+5.6%
Jun 2026
+6.6%
Mar 2026
+3.3%
Dec 2025
+7.8%
Sep 2025
+11.6%
Jun 2025
+10.0%
Mar 2025
+8.9%
Dec 2024
+82.9%
Sep 2024
+10.5%
At each fiscal year end
Single quarter
Free cash flow, TTM
$570.6M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM DT
FY Mar 2026
$529.7M
FY Mar 2025
$433.3M
FY Mar 2024
$351.6M
FY Mar 2023
$333.3M
FY Mar 2022
$233.2M
Jun 2026
$303.1M
Mar 2026
$212.4M
Dec 2025
$27.2M
Sep 2025
$27.8M
Jun 2025
$262.2M
Mar 2025
$148.2M
Dec 2024
$37.6M
Sep 2024
$20.1M
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term 2023-03-31 (39 months older than the period end) plus current 2022-09-30 (45 months older than the period end); equity 2026-06-30
Debt to equity DT
FY Mar 2026
0.00x
FY Mar 2025
0.00x
FY Mar 2024
0.00x
FY Mar 2023
0.00x
FY Mar 2022
0.21x
Jun 2026
0.00x
Mar 2026
0.00x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt DT
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
0.92x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+5.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity DT
FY Mar 2026
+6.2%
FY Mar 2025
+20.9%
FY Mar 2024
+8.6%
FY Mar 2023
+7.4%
FY Mar 2022
+4.3%
Jun 2026
+5.9%
Mar 2026
+6.2%
Dec 2025
+7.0%
Sep 2025
+20.6%
Jun 2025
+20.7%
Mar 2025
+20.9%
Dec 2024
+21.6%
Sep 2024
+8.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets DT
FY Mar 2026
+3.8%
FY Mar 2025
+12.8%
FY Mar 2024
+5.0%
FY Mar 2023
+4.1%
FY Mar 2022
+2.2%
Jun 2026
+3.7%
Mar 2026
+3.8%
Dec 2025
+4.7%
Sep 2025
+13.7%
Jun 2025
+13.4%
Mar 2025
+12.8%
Dec 2024
+14.3%
Sep 2024
+5.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+9.1%
operating income after a 49.4% effective tax rate, over long-term 2023-03-31 (39 months older than the period end) plus current 2022-09-30 (45 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital DT
FY Mar 2026
+8.5%
FY Mar 2025
n/a
FY Mar 2024
+11.2%
FY Mar 2023
n/a
FY Mar 2022
+5.5%
Jun 2026
+9.1%
Mar 2026
+8.5%
Dec 2025
+9.1%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
+11.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+9.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed DT
FY Mar 2026
+8.8%
FY Mar 2025
+7.3%
FY Mar 2024
+6.6%
FY Mar 2023
+5.5%
FY Mar 2022
+5.0%
Jun 2026
+9.2%
Mar 2026
+8.8%
Dec 2025
+9.0%
Sep 2025
+8.7%
Jun 2025
+7.9%
Mar 2025
+7.3%
Dec 2024
+6.8%
Sep 2024
+7.0%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
128.36x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing DT
FY Mar 2026
68.48x
FY Mar 2025
29.65x
FY Mar 2024
89.31x
FY Mar 2023
114.32x
FY Mar 2022
261.67x
Jun 2026
87.82x
Mar 2026
68.48x
Dec 2025
72.23x
Sep 2025
29.19x
Jun 2025
34.08x
Mar 2025
29.65x
Dec 2024
33.97x
Sep 2024
97.22x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$17.5B
market value at close 2026-10-26 on 2026-08-03 shares, plus long-term 2023-03-31 (39 months older than the period end) plus current 2022-09-30 (45 months older than the period end), minus cash 2026-06-30
Enterprise value DT
FY Mar 2026
$9.9B
FY Mar 2025
$13.1B
FY Mar 2024
$13.0B
FY Mar 2023
$11.7B
FY Mar 2022
$13.3B
Jun 2026
$11.7B
Mar 2026
$9.9B
Dec 2025
$12.0B
Sep 2025
$13.4B
Jun 2025
$15.3B
Mar 2025
$13.1B
Dec 2024
$15.3B
Sep 2024
$15.0B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.1%
TTM free cash flow over market value at close 2026-10-26
FCF yield DT
FY Mar 2026
+4.8%
FY Mar 2025
+3.1%
FY Mar 2024
+2.6%
FY Mar 2023
+2.7%
FY Mar 2022
+1.7%
Jun 2026
+4.5%
Mar 2026
+4.8%
Dec 2025
+3.6%
Sep 2025
+3.3%
Jun 2025
+2.8%
Mar 2025
+3.1%
Dec 2024
+2.5%
Sep 2024
+2.8%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -69%, PEG needs growth
PEG, trailing DT
FY Mar 2026
n/a
FY Mar 2025
0.14x
FY Mar 2024
2.20x
FY Mar 2023
1.08x
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
0.14x
Jun 2025
0.16x
Mar 2025
0.14x
Dec 2024
0.24x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
DT ranks highest on financial health (99th percentile) and growth (68th), and lowest on risk and compliance (39th), among Software & IT peers.
Profitability
57
Inputs
Return on equity+5.9% · 58 pct, sector of 286
Return on assets+3.7% · 67 pct, sector of 381
Return on invested capital+9.1% · 34 pct, sector of 78
Return on capital employed+9.2% · 69 pct, sector of 294
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 288
Cash flow to debtno debt to cover
Growth
68
Inputs
Revenue growth, YoY+18.8% · 69 pct, sector of 480
Backlog growth, YoY+17.9% · 66 pct, sector of 182
Insider conviction
39
Inputs
Net Form 4 buying (codes P and S), 180d-$16K · 79 pct, sector of 285
Insider buyers, 180d0 · 0 pct, sector of 290
Institutional and government
49
Inputs
Funds adding, latest quarter324 · 87 pct, sector of 415
Congress net buyers, 365d-1 · 11 pct, sector of 72
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
39
Inputs
Short interest, % of float+5.1% · 49 pct, sector of 530
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+16.6% · 30 pct, sector of 316
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
DT filings, in plain words
Are Dynatrace insiders buying or selling DT?
In the 180 days to 2026-10-28, Dynatrace insiders were net sellers, a net $2.9M across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded DT?
Yes. In the year to 2026-10-28, 0 House members disclosed buying DT and 1 House member disclosed selling it; the latest on record is a sale by Michael Patrick Guest dated 2026-01-09.
Are there planned insider sales of DT?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $2.9M of stock; the latest, by Greifeneder Bernd, was filed 2026-09-18.
Read the full summary
In the 180 days to 2026-10-28, Dynatrace insiders were net sellers of DT, a net $2.9M across purchases and sales reported on Form 4 by 1 seller. 14% of the 7 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-28, 0 members of Congress disclosed buying DT and 1 member disclosed selling it; the latest on record is a sale by Michael Patrick Guest dated 2026-01-09. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $2.9M of stock. 2 activist Schedule 13D filings in the last 180 days declared an intent to influence the company, the largest for 5.0% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.